FDA Inspection 1227494 — Jeremy Veenstra-Vanderweele, M.D.
The FDA completed an inspection of Jeremy Veenstra-Vanderweele, M.D. on Nov 30, 2023 in White Plains, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 30, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- White Plains, NY (United States)
Additional Details
Clinical Investigator (CI)